notifications to wholesalers
nationwide who received any inventory of the recalled products with
instructions for returning the recalled products. Patients with questions
about the recall should call the telephone number above, or contact their
health care providers.
This recall is being conducted with the knowledge of the U.S. Food and
Drug Administration (FDA). At this time, the company is unable to determine
when distribution of these products will resume.
Any adverse reactions experienced with the use of these products should
also be reported to the FDA's MedWatch Program by phone at 1-800-FDA-1088, by
fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville,
MD 20852-9787, or on the MedWatch website at http://www.fda.gov/medwatch.
The recall announcement is posted on http://www.kvpharma.com.
About KV Pharmaceutical Company
KV Pharmaceutical Company is a fully integrated specialty pharmaceutical
company that develops, manufactures, markets, and acquires
technology-distinguished branded and generic/non-branded prescription
pharmaceutical products. The company markets its technology distinguished
products through ETHEX Corporation, a national leader in generic
pharmaceuticals, and Ther-Rx Corporation, its branded drug subsidiary.
'/>"/>SOURCE KV Pharmaceutical Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
China Bio-Immunity Corporation Initiates Voluntary Recalls of Rabies Vaccines2.
Environmental Tectonics Corporation Announces the Sale of Two BARA-MED(R) XD Monoplace Hyperbaric Chambers3.
Sigma-Aldrich Corporations 4th Quarter 2008 Earnings Conference Call4.
CEL-SCI Corporation Announces 2008 Financial Results5.
Volcano Corporation Presentation at J.P. Morgan Conference to be Webcast6.
Mach One Corporation Enters Letter of Intent7.
CEL-SCI Corporation Releases Letter to Shareholders8.
Shareholder Class Action Filed Against Elan Corporation, plc by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP9.
Environmental Tectonics Corporation Announces Placement of Two Monoplace Chambers at St. John Wound Center; First Computer-controlled Hyperbaric Chambers in Oklahoma10.
Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza11.
Met-Pro Corporation Declares Quarterly Dividend